Literature DB >> 5240498

Busulphan lung.

B E Heard, R A Cooke.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5240498      PMCID： PMC471775          DOI： 10.1136/thx.23.2.187

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  16 in total

1.  Fibrous healing of old iatrogenic pulmonary edema ("hexamethonium lung").

Authors:  B E HEARD
Journal:  J Pathol Bacteriol       Date:  1962-01

2.  [Cytochemical and histoautoradiographic contribution to the study of the metabolism and synthesis of desoxyribonucleic acids in animal cells cultured in vitro. I. Cytophotometric and histoautoradiographic studies on desoxyribonucleic acids in myleran-treated fibroblasts].

Authors:  M CHEVREMONT; E BAECKELAND; J FREDERIC
Journal:  Biochem Pharmacol       Date:  1960-08       Impact factor: 5.858

3.  Interstitial pulmonary fibrosis following busulfan therapy.

Authors:  H OLINER; R SCHWARTZ; F RUBIO; W DAMESHEK
Journal:  Am J Med       Date:  1961-07       Impact factor: 4.965

4.  Transplacental transmission of busulfan (myleran) in a mother with leukemia. Production of fetal malformation and cytomegaly.

Authors:  I DIAMOND; M M ANDERSON; S R McCREADIE
Journal:  Pediatrics       Date:  1960-01       Impact factor: 7.124

5.  Epithelial atypias with chemotherapy in 100 acute childhood leukemias.

Authors:  J T WESTON; G H GUIN
Journal:  Cancer       Date:  1955 Jan-Feb       Impact factor: 6.860

6.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

7.  Lung changes during hexamethonium therapy for hypertension.

Authors:  I DONIACH; B MORRISON; R E STEINER
Journal:  Br Heart J       Date:  1954-01

8.  Syndrome resembling Addison's disease following prolonged treatment with busulphan.

Authors:  B P Harrold
Journal:  Br Med J       Date:  1966-02-19

9.  Cytologic dysplasia related to busulfan (Myleran) therapy. Report of a case.

Authors:  N GURELI; S W DENHAM; S W ROOT
Journal:  Obstet Gynecol       Date:  1963-04       Impact factor: 7.661

10.  Cataracts produced in rats by 1, 4-dimethanesulfonoxybutane (myleran).

Authors:  C SOLOMON; A E LIGHT; E J DE BEER
Journal:  AMA Arch Ophthalmol       Date:  1955-12
View more
  21 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  Pulmonary alveolar proteinosis. Respiratory medicine rounds of Stanford University Hospital.

Authors: 
Journal:  West J Med       Date:  1976-01

3.  Drug reactions and the lung.

Authors: 
Journal:  Br Med J       Date:  1976-10-30

4.  Lung disease caused by drugs.

Authors: 
Journal:  Br Med J       Date:  1969-09-27

5.  Diffuse pulmonary alveolar fibrosis.

Authors:  J G Scadding
Journal:  Thorax       Date:  1974-05       Impact factor: 9.139

6.  Drug-induced respiratory disorders.

Authors: 
Journal:  Br Med J       Date:  1973-05-12

7.  Pulmonary amyloidosis with impaired gas transfer.

Authors:  W A Crosbie; M L Lewis; I D Ramsay; D Doyle
Journal:  Thorax       Date:  1972-09       Impact factor: 9.139

8.  Electron microscopy of Crotalaria pulmonary hypertension.

Authors:  J M Kay; P Smith; D Heath
Journal:  Thorax       Date:  1969-09       Impact factor: 9.139

9.  Paraquat poisoning--lung transplantation.

Authors:  H Matthew; A Logan; M F Woodruff; B Heard
Journal:  Br Med J       Date:  1968-09-28

10.  An investigation of the chest radiographs in a controlled trial of busulphan, cyclophosphamide, and a placebo after resection for carcinoma of the lung.

Authors:  H Stott; R Stephens; W Fox; G Simon; D C Roy
Journal:  Thorax       Date:  1976-06       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.